Phase II Trial of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil in Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2018
At a glance
- Drugs Docetaxel (Primary) ; Carboplatin; Cisplatin; Fluorouracil
- Indications Adenocarcinoma; Head and neck cancer
- Focus Therapeutic Use
- 14 Sep 2018 Planned End Date changed from 1 Jun 2019 to 30 Jun 2019.
- 14 Sep 2018 Planned primary completion date changed from 1 Jun 2019 to 30 Jun 2019.
- 25 Aug 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.